Home » Topics » Regulatory

Regulatory
RSS

Paxil approved for generalized anxiety disorder

April 18, 2001

FDA issues approvable letter for Celebrex revised labeling

April 18, 2001

Hemopure approved for the first time in South Africa

April 11, 2001

FDA issues approvable letter for changes to Vioxx labeling

April 11, 2001

Roche files for E.U. approval of Xeloda/Taxotere combination for treatment of breast cancer

April 11, 2001

Combination therapies for restless legs syndrome devised by Boehringer Ingelheim

April 10, 2001

Schering-Plough patents use of antiallergic agents for CNS, vascular disorders

April 10, 2001

Use of modafinil in anorexia

April 10, 2001

AstraZeneca beta-blocker now available in U.S. for heart failure treatment

April 10, 2001

Health Canada approves Allergan's Botox for treatment of glabellar lines

April 10, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...